The size of the BioSurgery Market in LATAM is valued at USD 3.08 billion in 2022 and estimated to be growing at a CAGR of 9.74%, to reach USD 4.91 billion by 2027.
Biosurgery aid in the post-surgical care of patients or in the field of orthopedics and in the process of hard tissue regeneration in ortho-biologics as well. Most biosurgery products work on the principle of facilitating homeostasis and tissue healing in surgery.
Various synthetic and biologic products like anti-adhesive agents, homeostatic agents, surgical sealing agents & bone graft substitutes are used in the recovery of patients during and after complex and expensive surgical procedures. They work on the principle of accelerating the process of healing or provide faster wound sealing reducing blood loss during surgeries.
The major driver of the Latin America Bio Surgery market is the increased clearance of biosurgery products by regulatory authorities. This along with factors such as rising number of surgeries, increasing geriatric populations, lifestyle changes and rising need for effective blood loss management bolster the market growth in the region.
However, there are little-to-no reimbursements for biosurgery products and the costs associated with it are generally too high to be utilized by the common public. This along with the rising costs of surgical procedures in general acts as restraints for the market.
This research report on the Latin America BioSurgery Market has been segmented and sub-segmented into the following categories.
By Type:
By Application:
By Country:
Noteworthy companies playing a dominant role in the Latin American Biosurgery Market profiled in this report are Baxter International, C.R. Bard, Johnson & Johnson, Covidien plc., Getinge Group, B. Braun Melsungen AG, Cryolife Inc., Stryker Corporation, Hemostasis LLC., and Sanofi Group.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Type
5.1.1 Introduction
5.1.2 Sealants
5.1.2.1 Natural
5.1.2.2 Synthetic and Semi-Synthetic
5.1.3 Haemostatic Agents
5.1.4 Adhesion Barriers
5.1.4.1 Synthetic
5.1.4.2 Natural
5.1.5 Soft Tissue Attachments
5.1.5.1 Synthetic Meshes
5.1.5.2 Biological Meshes
5.1.7 Bone Graft Substitutes
5.1.7.1 Bone Allografts
5.1.7.2 Demineralized Bone Matrix
5.1.7.3 Bone Morphogenetic Proteins
5.1.7.4 Synthetic Bone Grafts
5.1.8 Staple Line Reinforcement Agents
5.1.9 Y-o-Y Growth Analysis, By Type
5.1.10 Market Attractiveness Analysis, By Type
5.1.11 Market Share Analysis, By Type
5.2 Application
5.2.1 Introduction
5.2.2 Orthopaedic
5.2.3 General
5.2.4 Neurological
5.2.5 Cardiovascular
5.2.6 Reconstructive
5.2.7 Gynaecological
5.2.8 Urological
5.2.9 Thoracic
5.2.10 Y-o-Y Growth Analysis, By Application
5.2.11 Market Attractiveness Analysis, By Application
5.2.12 Market Share Analysis, By Application
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Application
6.2 Brazil
6.3 Mexico
6.4 Rest of Latin America
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Baxter International
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 C.R. Bard
8.3 Covidien PLC
8.4 Johnson & Johnson
8.5 Sanofi Group
8.6 Atrium Medical Corporation
8.7 B.Braun Melsungen AG
8.8 Cryolife Inc.
8.9 Stryker Corporation
8.10 Haemostasis LLC
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
